(DINO) HF Sinclair - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4039491000
Stock: Fuels, Lubricants, Asphalt, Chemicals, Transportation
Total Rating 57
Risk 73
Buy Signal 0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 38.6% |
| Relative Tail Risk | -7.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.81 |
| Alpha | 71.56 |
| Character TTM | |
|---|---|
| Beta | 1.004 |
| Beta Downside | 2.367 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.35% |
| CAGR/Max DD | 0.16 |
EPS (Earnings per Share)
Revenue
Description: DINO HF Sinclair March 05, 2026
HF Sinclair Corporation (DINO) is a US-based independent energy company with operations across five segments: Refining, Renewables, Marketing, Lubricants and Specialties, and Midstream. This diversified structure is common among integrated energy companies seeking to capture value across the petroleum supply chain.
The company refines and markets various petroleum products, including gasoline, diesel fuel, jet fuel, and renewable diesel. Its refinery network spans six US states, with refined products distributed primarily in the Southwest, Rocky Mountains, and Pacific Northwest regions. The refining sector is characterized by its capital-intensive nature and sensitivity to crude oil prices and refined product demand.
DINO also produces and sells specialty lubricant products and chemicals. Additionally, it supports a network of approximately 1,600 Sinclair-branded stations through fuel supply and brand licensing agreements. The Midstream segment provides essential transportation, terminalling, and storage services for crude oil and petroleum products, a critical component of the energy infrastructure.
For more detailed financial analysis and performance metrics, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 579.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.44 > 1.0 |
| NWC/Revenue: -13.08% < 20% (prev 6.90%; Δ -19.97% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.31b > Net Income 579.0m |
| Net Debt (1.79b) to EBITDA (1.86b): 0.96 < 3 |
| Current Ratio: 0.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (182.8m) vs 12m ago -4.81% < -2% |
| Gross Margin: 8.23% > 18% (prev 0.11%; Δ 812.0% > 0.5%) |
| Asset Turnover: 162.1% > 50% (prev 171.7%; Δ -9.63% > 0%) |
| Interest Coverage Ratio: 4.40 > 6 (EBITDA TTM 1.86b / Interest Expense TTM 217.0m) |
Altman Z'' 1.41
| A: -0.21 (Total Current Assets 978.0m - Total Current Liabilities 4.49b) / Total Assets 16.51b |
| B: 0.33 (Retained Earnings 5.49b / Total Assets 16.51b) |
| C: 0.06 (EBIT TTM 954.0m / Avg Total Assets 16.58b) |
| D: 1.27 (Book Value of Equity 9.25b / Total Liabilities 7.26b) |
| Altman-Z'' Score: 1.41 = BB |
Beneish M
| DSRI: none (Receivables none/1.32b, Revenue 26.87b/28.58b) |
| GMI: 1.36 (GM 8.23% / 11.23%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.94 (Revenue 26.87b / 28.58b) |
| TATA: -0.04 (NI 579.0m - CFO 1.31b) / TA 16.51b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of DINO shares?
As of March 06, 2026, the stock is trading at USD 57.17 with a total of 4,355,421 shares traded.
Over the past week, the price has changed by +13.81%, over one month by +2.03%, over three months by +15.33% and over the past year by +95.10%.
Over the past week, the price has changed by +13.81%, over one month by +2.03%, over three months by +15.33% and over the past year by +95.10%.
Is DINO a buy, sell or hold?
HF Sinclair has received a consensus analysts rating of 3.82.
Therefore, it is recommended to buy DINO.
- StrongBuy: 4
- Buy: 6
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DINO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 58.9 | 3.1% |
| Analysts Target Price | 58.9 | 3.1% |
DINO Fundamental Data Overview March 02, 2026
P/E Trailing = 16.237
P/E Forward = 9.5694
P/S = 0.3482
P/B = 0.9946
P/EG = 7.7116
Revenue TTM = 26.87b USD
EBIT TTM = 954.0m USD
EBITDA TTM = 1.86b USD
Long Term Debt = 2.77b USD (from longTermDebt, two quarters ago)
Short Term Debt = 99.0m USD (from shortTermDebt, two quarters ago)
Debt = 2.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.79b USD (from netDebt column, last quarter)
Enterprise Value = 11.15b USD (9.36b + Debt 2.77b - CCE 978.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 954.0m / Interest Expense TTM 217.0m)
EV/FCF = 17.31x (Enterprise Value 11.15b / FCF TTM 644.0m)
FCF Yield = 5.78% (FCF TTM 644.0m / Enterprise Value 11.15b)
FCF Margin = 2.40% (FCF TTM 644.0m / Revenue TTM 26.87b)
Net Margin = 2.15% (Net Income TTM 579.0m / Revenue TTM 26.87b)
Gross Margin = 8.23% ((Revenue TTM 26.87b - Cost of Revenue TTM 24.66b) / Revenue TTM)
Gross Margin QoQ = 2.03% (prev 20.59%)
Tobins Q-Ratio = 0.68 (Enterprise Value 11.15b / Total Assets 16.51b)
Interest Expense / Debt = 2.67% (Interest Expense 74.0m / Debt 2.77b)
Taxrate = 19.95% (146.0m / 732.0m)
NOPAT = 763.7m (EBIT 954.0m * (1 - 19.95%))
Current Ratio = 0.22 (Total Current Assets 978.0m / Total Current Liabilities 4.49b)
Debt / Equity = 0.30 (Debt 2.77b / totalStockholderEquity, last quarter 9.25b)
Debt / EBITDA = 0.96 (Net Debt 1.79b / EBITDA 1.86b)
Debt / FCF = 2.78 (Net Debt 1.79b / FCF TTM 644.0m)
Total Stockholder Equity = 9.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.49% (Net Income 579.0m / Total Assets 16.51b)
RoE = 6.23% (Net Income TTM 579.0m / Total Stockholder Equity 9.29b)
RoCE = 7.91% (EBIT 954.0m / Capital Employed (Equity 9.29b + L.T.Debt 2.77b))
RoIC = 6.36% (NOPAT 763.7m / Invested Capital 12.01b)
WACC = 7.90% (E(9.36b)/V(12.12b) * Re(9.61%) + D(2.77b)/V(12.12b) * Rd(2.67%) * (1-Tc(0.20)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.13%
[DCF] Terminal Value 71.71% ; FCFF base≈742.1m ; Y1≈510.4m ; Y5≈255.7m
[DCF] Fair Price = 17.52 (EV 5.01b - Net Debt 1.79b = Equity 3.22b / Shares 183.9m; r=7.90% [WACC]; 5y FCF grow -36.54% → 2.90% )
EPS Correlation: -49.86 | EPS CAGR: 5.26% | SUE: 1.10 | # QB: 3
Revenue Correlation: -74.82 | Revenue CAGR: -3.75% | SUE: 1.17 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.61 | Chg7d=-0.099 | Chg30d=-0.045 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=4.30 | Chg7d=-0.700 | Chg30d=-0.762 | Revisions Net=-1 | Growth EPS=-15.0% | Growth Revenue=-5.3%
EPS next Year (2027-12-31): EPS=4.49 | Chg7d=-0.908 | Chg30d=-1.210 | Revisions Net=-1 | Growth EPS=+4.4% | Growth Revenue=+3.0%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 9.6% - Earnings Yield 6.2%)
[Growth] Growth Spread = -5.9% (Analyst -2.4% - Implied 3.5%)
P/E Forward = 9.5694
P/S = 0.3482
P/B = 0.9946
P/EG = 7.7116
Revenue TTM = 26.87b USD
EBIT TTM = 954.0m USD
EBITDA TTM = 1.86b USD
Long Term Debt = 2.77b USD (from longTermDebt, two quarters ago)
Short Term Debt = 99.0m USD (from shortTermDebt, two quarters ago)
Debt = 2.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.79b USD (from netDebt column, last quarter)
Enterprise Value = 11.15b USD (9.36b + Debt 2.77b - CCE 978.0m)
Interest Coverage Ratio = 4.40 (Ebit TTM 954.0m / Interest Expense TTM 217.0m)
EV/FCF = 17.31x (Enterprise Value 11.15b / FCF TTM 644.0m)
FCF Yield = 5.78% (FCF TTM 644.0m / Enterprise Value 11.15b)
FCF Margin = 2.40% (FCF TTM 644.0m / Revenue TTM 26.87b)
Net Margin = 2.15% (Net Income TTM 579.0m / Revenue TTM 26.87b)
Gross Margin = 8.23% ((Revenue TTM 26.87b - Cost of Revenue TTM 24.66b) / Revenue TTM)
Gross Margin QoQ = 2.03% (prev 20.59%)
Tobins Q-Ratio = 0.68 (Enterprise Value 11.15b / Total Assets 16.51b)
Interest Expense / Debt = 2.67% (Interest Expense 74.0m / Debt 2.77b)
Taxrate = 19.95% (146.0m / 732.0m)
NOPAT = 763.7m (EBIT 954.0m * (1 - 19.95%))
Current Ratio = 0.22 (Total Current Assets 978.0m / Total Current Liabilities 4.49b)
Debt / Equity = 0.30 (Debt 2.77b / totalStockholderEquity, last quarter 9.25b)
Debt / EBITDA = 0.96 (Net Debt 1.79b / EBITDA 1.86b)
Debt / FCF = 2.78 (Net Debt 1.79b / FCF TTM 644.0m)
Total Stockholder Equity = 9.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.49% (Net Income 579.0m / Total Assets 16.51b)
RoE = 6.23% (Net Income TTM 579.0m / Total Stockholder Equity 9.29b)
RoCE = 7.91% (EBIT 954.0m / Capital Employed (Equity 9.29b + L.T.Debt 2.77b))
RoIC = 6.36% (NOPAT 763.7m / Invested Capital 12.01b)
WACC = 7.90% (E(9.36b)/V(12.12b) * Re(9.61%) + D(2.77b)/V(12.12b) * Rd(2.67%) * (1-Tc(0.20)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.13%
[DCF] Terminal Value 71.71% ; FCFF base≈742.1m ; Y1≈510.4m ; Y5≈255.7m
[DCF] Fair Price = 17.52 (EV 5.01b - Net Debt 1.79b = Equity 3.22b / Shares 183.9m; r=7.90% [WACC]; 5y FCF grow -36.54% → 2.90% )
EPS Correlation: -49.86 | EPS CAGR: 5.26% | SUE: 1.10 | # QB: 3
Revenue Correlation: -74.82 | Revenue CAGR: -3.75% | SUE: 1.17 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.61 | Chg7d=-0.099 | Chg30d=-0.045 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-12-31): EPS=4.30 | Chg7d=-0.700 | Chg30d=-0.762 | Revisions Net=-1 | Growth EPS=-15.0% | Growth Revenue=-5.3%
EPS next Year (2027-12-31): EPS=4.49 | Chg7d=-0.908 | Chg30d=-1.210 | Revisions Net=-1 | Growth EPS=+4.4% | Growth Revenue=+3.0%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.5% (Discount Rate 9.6% - Earnings Yield 6.2%)
[Growth] Growth Spread = -5.9% (Analyst -2.4% - Implied 3.5%)